Leaphy 1A

Sustainable Development Tax Shelter
Equity Belgium 79 investors
Leaphy, the single trusted source for information about medicines and more
Pre money valuation
Equity offered
Amount raised
0 days
Minimum target
163% funded
This campaign has been closed

Geert De Pelsmaeker


Geert De Pelsmaeker has a Masters in nursing, health economics (university of Brussel) VUB) and and in Business Management (University of KU Leuven). He started his career in the pharmaceutical industry where he had several positions in sales and marketing. He launched Zolpidem (Stilnoct) in the Belgian Market. In 1995 he started his own company in CRM for the pharmaceutical industry. He was successful with this product whole over Europe. When this company was bought by Dendride (IMS now). Afterwards he started a new company “MedDb” for medical and pharmaceutical data management

Guilherme Monteiro Ferreira

Board member

Guilherme Monteiro Ferreira is a pharmacist by education (University of Lisbon). Gui has more than 7 years of experience in public and governmental affairs. In addition he has a large network of European pharmacists due to several years of involvement in the European Pharmaceutical Students Association (EPSA). Gui is, as a board member, strategic adviser and will become COO of Leaphy, supporting the country expansion.

Maarten Van Baelen

Board member

Maarten Van Baelen is a pharmacists by education (KU Leuven) and holds a Master in Business Administration from Solvay Business School (Brussels) and École des Ponts (Paris). Maarten worked for more than 12 years in the pharmaceutical industry. In the past he has been involved in the foundations of non-profit organisations such as LMS Events and the European Medicines Verification Organisation (EMVO). Maarten has developed the Leaphy business plan and is, as board member, strategic adviser to Leaphy.


This business qualifies for the startup tax shelter. If you meet the conditions, 45% of your investment will be reducted from your personal income taxes. Read more…
Please note €168,900 remains available for Tax Shelter investments.